- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 295/182 - Radicals derived from carboxylic acids
Patent holdings for IPC class C07D 295/182
Total number of patents in this class: 64
10-year publication summary
4
|
4
|
3
|
4
|
2
|
5
|
3
|
4
|
1
|
1
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Newron Pharmaceuticals S.p.A. | 64 |
12 |
AstraZeneca AB | 2962 |
4 |
Dongguk University Industry-Academic Cooperation Foundation | 414 |
2 |
Sunovion Pharmaceuticals Inc. | 290 |
2 |
Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd. | 32 |
2 |
Nanjing Redwood Fine Chemical Co., Ltd | 2 |
2 |
F. Hoffmann-La Roche AG | 7951 |
1 |
Bayer Cropscience AG | 2136 |
1 |
The General Hospital Corporation | 4655 |
1 |
Agency for Science, Technology and Research | 3570 |
1 |
W. L. Gore & Associates, Inc. | 2686 |
1 |
Abide Therapeutics, Inc. | 26 |
1 |
Ambrilia Biopharma Inc. | 7 |
1 |
The Brigham and Women's Hospital, Inc. | 2147 |
1 |
Catabasis Pharmaceuticals, Inc. | 36 |
1 |
Cytokinetics, Inc. | 268 |
1 |
Fudan University | 646 |
1 |
Imago Biosciences, Inc. | 38 |
1 |
Kraton Polymers U.S. LLC | 201 |
1 |
Metabolys | 7 |
1 |
Other owners | 26 |